Non-Invasive Markers for the Diagnosis of MASLD

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, especially in patients with obesity. Here, Dr. Johanna Brix, a leading diabetologist and obesity specialist from Austria, delves into the critical role of non-invasive markers in diagnosing MASLD.

  • Pre Questionnaire
  • Video
  • Post Questionnaire
[gravityform id="76" title="false" description="false" ajax="true"]
  • Dr. Johanna Brix
  • MASLD
  • Video views: 237
  • Rating: 6.7 out of 10

View all CPD

EASO has received funding to support components of the 5-MIN CPD programme via an unrestricted grant from Boehringer-Ingelheim. Boehringer-Ingelheim had no influence over the content of any of the modules.